Please note I don't want to put a dampener on this subject.
I'm certain that at some point there will well be a new medical discovery that can actually do more for PBC patients than the current standard with urso.
Hello, I would like to inform members of a new clinical trial for participants with Primary Biliary Cirrhosis (PBC). Intercept Pharmaceuticals is sponsoring this trial; over 60 centers in North America and Europe are participating. The trial is recruiting PBC patients who have been taking UDCA (URSO) for at least 12 months or are unable to tolerate UDCA and stopped taking it at least three months ago. A website with information about the clinical trial and trial locations can be found at pbc-study.com. The website also contains general information about participating in clinical trials and a frequently asked questions section. If you are interested in learning more about this PBC trial, or have a friend or relative who may be interested, please check it out.
Please note I am a representative of Intercept and am not able to respond to questions posted here.
Hi I am a 44 year old female who is presently on a study with obethicolic acid is there anyone else who is on this study reading this,I am willing to be
a test subject so future pbc sufferors can benefit , it would be nice to be in touch with other study members ?
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Good news
Obeticholic approved in England, Wales and Northern Ireland
New Biopsy report: The submitted biopsy does not have any diagnostic features of primary biliary cirrhosis
Primary biliary cirrhosis 
Obeticholic acid 
